18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway

Figure 5 Effect of 18β-glycyrrhetinic acid on subcutaneous tumor growth in BALB/c nude mice. A: Comparison of back tumor in the cisplatin (DDP), 18β-glycyrrhetinic acid (18β-GRA) and control groups; B: Comparison of back tumor volume in the DDP, 18β-GRA and control groups; C: Effect of tumor volume growth in the DDP, 18β-GRA and control groups; D: Effect of body weight in the DDP, 18β-GRA and control groups; E: Effect of water-intake in the DDP, 18β-GRA and control groups; F: Effect of food-intake in the DDP, 18β-GRA and control groups. The data is represented as the mean ± SD. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. 18β-GRA: 18β-glycyrrhetinic acid; DDP: Cisplatin.